Panel Discussion | Consensus on Retrograde Approach

Sunday, March 9, 2025

9:41 AM – 9:55 AM ET

Panel Moderator(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
Kevin Croce, MD, PhD

Director of CTO and Complex PCI Programs
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.
Carlo Di Mario, MD

Professor
University of Florence
Florence, Toscana, Italy

Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)
MP

Megha Prasad, MD

Assistant professor
Columbia university

Disclosure information not submitted.

Panel Discussant(s)

Khaldoon Alaswad, MD, FACC, FSCAI

Director, Catheterization Laboratory
Henry Ford Hospital and Health System
Detroit, Michigan, United States

Disclosure(s): No financial relationships to disclose
Salman Arain, MD, FACC, FSCAI

Associate Professor of Medicine - Cardiology
University of Texas Health Sciences Center - Houston
Houston, Texas, United States

Disclosure(s): Boston Scientific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Dimitri Karmpaliotis, MD, PhD, FSCAI

NYPH/Columbia University Medical Center
New York, New York, United States

Disclosure information not submitted.
Adhir Shroff, MD, MPH

Clinical Chief of Cardiology
University of Illinois at Chicago/Jesse Brown Medical Center
Chicago, Illinois, United States

Disclosure information not submitted.
Gerald S. Werner, MD, PhD, FSCAI

Director
Klinikum Darmstadt GmbH
Darmstadt, Hessen, Germany

Disclosure information not submitted.
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Carlo Di Mario, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)

Khaldoon Alaswad, MD, FACC, FSCAI: No financial relationships to disclose

Salman Arain, MD, FACC, FSCAI: Boston Scientific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Masahisa Yamane, MD: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)